Back to UBS Group AG UBS Group AG

NNNNNNNN
6 quarters

Position history for UBS Group AGUBS Group AG's holdings in ANBIO BIOTECHNOLOGY

Yes. Ubs holds 828 shares of NNNN (Anbio Biotechnology), worth $11,352, as of its Q2 2026 13F filing. It reduced the position by 5,511 shares (-86.9%) from Q1 2026. Ubs has held NNNN since Q1 2025, across 6 quarterly 13F filings.

Current Value

$11,352

Current Shares

828

Total Value Change

-$31,453

Total Shares Change

-4,910

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
828
-86.9%
$11,3520.0%$13.71
0
2026-Q1
Increased
6,339
+122.5%
$162,8490.0%$25.69
25
2025-Q4
Increased
2,849
+196.8%
$85,6690.0%$30.07
24
2025-Q3
Decreased
960
-91.0%
$35,7600.0%$37.25
0
2025-Q2
Increased
10,695
+86.4%
$338,6040.0%$31.66
37
2025-Q1
New
5,738
-
$42,8050.0%$7.46
31

Other major holders of NNNN: GEODE CAPITAL MANAGEMENT, LLC, MARSHALL WACE, LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used